|
|
Volumn 47, Issue SUPPL. 3, 2001, Pages 38-43
|
|
Latest industry information on the safety profile of levofloxacin in Japan
a
|
|
Author keywords
Adverse drug reaction; Fluoroquinolones; Levofloxacin; Post marketing surveillance data; Safety; Toxicity
|
|
Indexed keywords
ENOXACIN;
GREPAFLOXACIN;
LEVOFLOXACIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SPARFLOXACIN;
TEMAFLOXACIN;
TROVAFLOXACIN;
CARDIOTOXICITY;
CONFERENCE PAPER;
CONVULSION;
DISEASE SEVERITY;
DRUG INDUSTRY;
DRUG SURVEILLANCE PROGRAM;
HEART CONDUCTION;
HEMOLYTIC ANEMIA;
HUMAN;
JAPAN;
LIVER TOXICITY;
PHOTOTOXICITY;
PRIORITY JOURNAL;
QT INTERVAL;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANTI-INFECTIVE AGENTS;
CENTRAL NERVOUS SYSTEM;
DERMATITIS, PHOTOTOXIC;
DRUG INDUSTRY;
FLUOROQUINOLONES;
HEART DISEASES;
HUMANS;
JAPAN;
LIVER DISEASES;
NAPHTHYRIDINES;
OFLOXACIN;
SEIZURES;
SUBSTANCE WITHDRAWAL SYNDROME;
|
|
EID: 0034851752
PISSN: 00093157
EISSN: None
Source Type: Journal
DOI: 10.1159/000057843 Document Type: Conference Paper |
|
Times cited : (24)
|
|
References (0)
|
